BOSTON, MA—For patients undergoing transradial coronary procedures, a short course of rivaroxaban (Xarelto; Bayer/Janssen) reduces the rate of radial artery occlusion without significantly increasing ...

Coronary bypass surgery patients who received a radial artery as their second bypass conduit had significantly better 10-year survival than did patients who received a saphenous vein graft in a ...

One-year findings from the Distal versus Proximal Radial Artery Access for Cardiac Catheterization and Intervention (DIPRA) study were presented today as late-breaking clinical research at the Society ...

In patients with peripheral artery disease, radial artery access is safe and feasible for peripheral vascular intervention. Radial artery access is safe and feasible for peripheral vascular ...

Major cardiac events were fewer at 5 years in patients receiving a radial artery graft as the second conduit in coronary bypass surgery (CABG) vs a saphenous-vein graft (SVG) in a patient-level ...